Minmin Jing – Trademark Portfolio

Entity Type: 01

Minmin Jing owns a portfolio of 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as AOSUHA, ROBMOR, and INNERFOLIO. Of these, 3 are registered. The portfolio spans 3 Nice Classification classes, led by Class 8 (Hand Tools) and Class 18 (Leather Goods). Headquartered in Shanxi Province.

Group 1, Guonan Village, Monan Town

Ruicheng County

Shanxi Province 044607 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ROBMOR
ROBMOR
Registered 2023
AOSUHA
AOSUHA
Registered 2023

Trademark Classifications

Minmin Jing's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

8
Hand Tools (1 filing)

Hand tools and implements (hand-operated); cutlery; side arms; razors

18
Leather Goods (1 filing)

Leather and imitations of leather; animal skins, hides; trunks and travelling bags

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Minmin Jing have?

Minmin Jing has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Minmin Jing file in?

Minmin Jing files trademarks across 3 Nice Classification classes. The most active classes are Class 8 (Hand Tools), Class 18 (Leather Goods), Class 10 (Medical Apparatus). Class 8 covers hand tools and implements (hand-operated); cutlery; side arms; razors.

What are Minmin Jing's most well-known trademarks?

Minmin Jing's registered trademark portfolio includes well-known marks such as AOSUHA, ROBMOR, and INNERFOLIO. These are among 3 currently registered trademarks in the portfolio.

What is Minmin Jing's trademark registration success rate?

Minmin Jing has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.